Cyclodextrins in drug delivery: An updated review

被引:942
作者
Challa, R [1 ]
Ahuja, A [1 ]
Ali, J [1 ]
Khar, RK [1 ]
机构
[1] Hamdard Univ, Fac Pharm, Dept Pharmaceut, New Delhi 110062, India
关键词
cyclodextrins; drug formulation; drug delivery; novel delivery systems; excipients;
D O I
10.1208/pt060243
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this review is to discuss and summarize some of the interesting findings and applications of cyclodextrins (CDs) and their derivatives in different areas of drug delivery, particularly in protein and peptide drug delivery and gene delivery. The article highlights important CD applications in the design of various novel delivery systems like liposomes, microspheres, microcapsules, and nanoparticles. In addition to their well-known effects on drug solubility and dissolution, bioavailability, safety, and stability, their use as excipients in drug formulation are also discussed in this article. The article also focuses on various factors influencing inclusion complex formation because an understanding of the same is necessary for proper handling of these versatile materials. Some important considerations in selecting CDs in drug formulation such as their commercial availability, regulatory status, and patent status are also summarized. CDs, because of their continuing ability to find several novel applications in drug delivery, are expected to solve many problems associated with the delivery of different novel drugs through different delivery routes.
引用
收藏
页数:29
相关论文
共 243 条
[1]  
Aggarwal S, 2002, PHARMAZIE, V57, P191
[2]  
Ahn HJ, 1997, DRUG DEV IND PHARM, V23, P397
[3]  
Akasaka H, 2000, CHEM PHARM BULL, V48, P1986
[4]   Influence of hydroxypropyl β-cyclodextrin on the corneal permeation of pilocarpine [J].
Aktas, Y ;
Ünlü, N ;
Orhan, M ;
Irkeç, M ;
Hincal, AA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (02) :223-230
[5]  
[Anonymous], 1965, ADV ANAL CHEM INSTRU
[6]  
[Anonymous], PHARM TECHNOL INT
[7]   Study of omeprazole-γ-cyclodextrin complexation in the solid state [J].
Arias, MJ ;
Moyano, JR ;
Muñoz, P ;
Ginés, JM ;
Justo, A ;
Giordano, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (03) :253-259
[8]   Study of the inclusion of gliclazide in α-cyclodextrin [J].
Arias-Blanco, MJ ;
Moyano, JR ;
Perez-Martinez, JI ;
Gines, JM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (1-2) :275-279
[9]   Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-β-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers [J].
Arima, H ;
Yunomae, K ;
Morikawa, T ;
Hirayama, F ;
Uekama, K .
PHARMACEUTICAL RESEARCH, 2004, 21 (04) :625-634
[10]   Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats [J].
Arima, H ;
Yunomae, K ;
Miyake, K ;
Irie, T ;
Hirayama, F ;
Uekama, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (06) :690-701